Director Ann D. Rhoads of Globus Medical Inc filed a Form 4 on November 5, 2026, disclosing the sale of 5,000 shares of Class A Common Stock on November 4, 2026, at $85 per share under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Seller: Ann D. Rhoads, a Director of Globus Medical Inc (NYSE:GMED)
  • Transaction: 5,000 shares of Class A Common Stock disposed of (transaction code S) on November 4, 2026
  • Price: $85 per share
  • Remaining holdings: 35,384 shares of Class A Common Stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan dated June 10, 2026

Ann D. Rhoads Reports November 4 Sale Under 10b5-1 Plan

According to the filing, Director Ann D. Rhoads sold 5,000 shares of Globus Medical Inc Class A Common Stock on November 4, 2026, at a price of $85 per share. The transaction was reported on a Form 4 filed with the SEC on November 5, 2026. The form indicates the sale was a direct disposition, coded "S," and was carried out pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c), as indicated by the checked box on the form.

The filing notes in its explanation of responses that "this sale was effectuated pursuant to a Rule 10b5-1 trading plan dated June 10, 2026 executed by the reporting person." Following the reported transaction, Rhoads directly held 35,384 shares of Class A Common Stock, according to the filing. No derivative securities transactions were reported in Table II.

The Form 4 was signed by Kelly G. Huller as Attorney-in-Fact on November 5, 2026. Rhoads's address is listed as Valley Forge Business Center, 2560 General Armistead Avenue, Audubon, Pennsylvania 19403.

What Was Disclosed

Globus Medical Inc Director Ann D. Rhoads disclosed the sale of 5,000 shares of Class A Common Stock at $85 per share on November 4, 2026, under a Rule 10b5-1 plan established June 10, 2026, leaving her with 35,384 directly held shares.